Skip to main content

US Hearing Aids Market Size [2022-2029] worth USD 5.86 Billion | exhibiting a CAGR of 7.8%

US Hearing Aids Market Covered By Key Companies – Sonova (Switzerland) , Demant A/S (Denmark) , GN Store Nord A/S (Denmark) , Cochlear Ltd (Australia) , WS Audiology (Denmark) , RION Co., Ltd. (Japan) , Starkey (U.S.) , MED-EL (Medical Electronics) (Austria)

Pune, India, March 30, 2022 (GLOBE NEWSWIRE) — The US hearing aids market size was USD 3.31 billion in 2021. The market is projected to grow from USD 3.46 billion in 2022 to USD 5.86 billion in 2029 at a CAGR of 7.8% during the 2022-2029 period. This vital information is presented by Fortune Business Insights™, in its report, titled, “US Hearing Aids Market, 2022-2029.” Factors such as widening applications, technological advancements, and rising focus on restoring hearing devices will boost the growth of the market during the forecast period. Additionally, rising insurance coverage and increasing product launches will increase the footprint of the market.

Key Industry Development

January 2021: W/S audiology launched Signia Active Pro earbud-styled hearing aids that will possess a higher-tech audiological advantage. This product further boasts Bluetooth connectivity, the ability to receive phone calls among a range of other features, and is aimed at increasing utility for its consumers.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-hearing-aids-market-105653


Worldwide US Hearing Aids Market Report 2022 – 2028 contains methodical and highlight point data in regards to US Hearing Aids Market. The report contains brief Introduction, Market investigation by types , applications and regions. Report additionally contains top Manufacturers Profiles (Name of the maker, Business Overview, Type and Applications and Sales, Price, Revenue, Gross Margin and Market Share). Report likewise give worldwide and local Sales Channel, Distributors, Traders and Dealers with US Hearing Aids Market Analysis Value And next four Years gauge esteem.


Report Scope & Segmentation :

Report Coverage Details
Forecast Period 2022-2029
Forecast Period 2022 to 2029 CAGR 7.8%
2029 Value Projection USD 5.86 billion
Base Year 2022
Market Size in 2022 USD 3.46 billion
Historical Data for 2018-2020
No. of Pages 88
Segments covered By Product, By Age, By Distribution Channel
Growth Drivers The increasing insurance coverage, coupled with new product launches by key players, would support market growth during the forecast period.
The increasing aging population in the U.S. susceptible to auditory loss is likely to support market growth.


Market Growth Drivers:

  • Factors, such as rising demand for cost-effective products, rising cases regarding hearing losses, and increasing consumer pool, will boost the US hearing aids market growth during the forecast period. Additionally, increasing geriatric population, favorable regulatory policies, and rising government initiatives will increase the footprint of the market. Also, increasing adoption of technologically advanced devices will fuel the growth of the market.
  • However, higher costs of devices will limit the growth of the market during the forecast period. Additionally, lack of favorable reimbursement policies will hinder the growth of the market.

Click here to get the short-term and long-term impact of COVID-19 on this Market:

https://www.fortunebusinessinsights.com/u-s-hearing-aids-market-105653


Segments

Based on product, the market is divided into hearing devices and hearing implants. The hearing devices segment can be further broken down into behind the ear (BTE), in the ear (ITE), receiver in the canal (RIC), completely in the canal (CIC), and others (invisible in the canal).

By age, the market is segmented into adult and pediatric.

With respect to distribution channel, the market is fragmented into government services, manufacturer-owned retail networks, national retailers, independent retailers/small chains, and online retailers.

Competitive Landscape

The sector of the U.S. hearing aids is extremely competitive due to the presence of many well-established and emerging players. In its current scope, Sonova and Demant A/S were leading the US hearing aids market share in 2021 and accounted for a majority of the revenue. Other players are focused on expanding their market share by employing strategic tactics, including mergers & acquisitions, collaborations, and introducing novel products in their portfolio. For example, in May 2021, Sonova announced acquiring the consumer audio division of Sennheiser for strengthening its portfolio and integrating wider applications for consumers. Others players, including Cochlear Ltd, WS Audiology, and Starkey held a considerable market share by increasing their offerings in the space.

Quick Buy – US Hearing Aids Market:

https://www.fortunebusinessinsights.com/checkout-page/105653


The Report Lists the Key Companies in the Global Market

  • Sonova (Switzerland)
  • Demant A/S (Denmark)
  • GN Store Nord A/S (Denmark)
  • Cochlear Ltd (Australia)
  • WS Audiology (Denmark)
  • RION Co., Ltd. (Japan)
  • Starkey (U.S.)
  • MED-EL (Medical Electronics) (Austria)

Table of Contents

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Key Industry Developments – Acquisitions, Mergers, and Partnerships
    • Penetration of Hearing Aids for Key Countries
    • New Product Launches 
    • Epidemiology of Hearing Loss – USA
    • Prevalence of Hearing Loss, by States, U.S, 2021
    • Number of Audiologists, Hearing Aid Specialists, Retail Outlets
    • Partnerships Between Manufacturers and Third party Referral Companies/ Vendors
    • Impact of COVID-19 on the U.S. Hearing Aids & Implants Market

ToC Continued..


Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-hearing-aids-market-105653


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.